Johnson & Johnson Innovation - JJDC, Inc. | Activity | F4

Team Portfolio Raise Essays

F4/Johnson & Johnson Innovation - JJDC, Inc./Activity

Johnson & Johnson Innovation - JJDC, Inc. Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

News

JJDC reported more than 100 active portfolio companies, 35 investments, 6 exits and $3.2B+ invested since 2016.

JJDC 2025 year in review

Johnson & Johnson Innovation - JJDC, Inc.

jnjinnovation.com

Added recently

Investment

JJDC led Ronovo Surgical's $67M Series D.

Ronovo Surgical

Ronovo Surgical Johnson & Johnson Innovation - JJDC, Inc.

jnjinnovation.com

Added recently

Investment

JJDC invested in Distalmotion, a soft tissue surgical robotics company, in Q1 2025.

Distalmotion

Distalmotion Johnson & Johnson Innovation - JJDC, Inc.

jnjinnovation.com

Added recently

Exit

HistoSonics was acquired by an investor consortium at about $2.25B; JJDC led or co-led two of its rounds.

HistoSonics

HistoSonics Johnson & Johnson Innovation - JJDC, Inc.

jnjinnovation.comAUG 2025

AUG 2025

Investment

JJDC invested in Prazer Therapeutics, a targeted protein degradation company.

Prazer Therapeutics

Prazer Therapeutics Johnson & Johnson Innovation - JJDC, Inc.

jnjinnovation.comMAR 2025

MAR 2025

Exit

AbbVie's $1.4B acquisition of Aliada Therapeutics, co-founded by JJDC and RA Capital, closed.

Aliada Therapeutics

Aliada Therapeutics Johnson & Johnson Innovation - JJDC, Inc.

jnjinnovation.comDEC 2024

DEC 2024

Investment

JJDC, Forbion Ventures and Novartis Venture Fund co-led Citryll's EUR 85M Series B.

Citryll

Citryll Johnson & Johnson Innovation - JJDC, Inc.

jnjinnovation.comNOV 2024

NOV 2024